Intellectual property


Expanding our intellectual property is essential in order for us to successfully pursue our strategy and achieve our ambition.

Since 2010, LNC has secured a number of patents for its Stablor® product. Its formulation and clinical results are therefore protected, with exclusive rights applicable in 4 major pharmaceutical markets: the United States, Europe, South America and China.

We intend to build a strong IP position in the Christensenella space by filing our own IP (applications have been filed in EU and US), by licensing in available patents and patent applications from academics and by acquiring proprietary Christensenella strains.

In September 2018, we acquired an exclusive licence for the Christensenella patents from Cornell University (Ithaca, NY, USA) in order to pursue our development program.

Lastly, we are actively scouting at the international level for patent licensing opportunities, as well as new patents to acquire in order to continue expanding our intellectual property portfolio.

Microbiome & us
Jan 13, 2020
We are looking for Clinical Project Manager | WHAT WE OFFER An exciting opportunity to dive in and begin your career...
> more
Dec 11, 2019
LNC Therapeutics and the National Institute for Agricultural Research (INRA) sign research partnership to study anti-...
> more
Press / Media
Nov 12, 2019
Biotechs investments disrupt Big Pharma business model The pharmaceutical industry is in a state of flux, with...
> more
Sep 6, 2019
Chaque semaine, Maddyness dresse le bilan des levées de fonds de la semaine qui vient de s’écouler. Cette semaine,...
> more
Dec 6, 2019
The term “microbiome” refers to the collection of microorganisms (or microbiota) – including bacteria, viruses and...
> more
Oct 28, 2019
Jillian L. Waters, Ruth E. Ley The Christensenellaceae, a recently described family in the phylum Firmicutes, is emerging...
> more
now on twitter
LNC Therapeutics

Researchers discovered that rats with spinal injuries experienced changes to their gut bacteria and a rise in anxie…

LNC Therapeutics © 2020 - all rights reserved terms and conditions